Hypoxia in tumors is generally associated with chemoresistance and radioresistance. However, the correlation between the heterodimeric hypoxia-inducible factor-1 (HIF-1) and the multidrug resistance transporter P-glycoprotein (P-gp) has not been investigated. Herein, we demonstrate that with increasing size of DU-145 prostate multicellular tumor spheroids the pericellular oxygen pressure and the generation of reactive oxygen species decreased, whereas the α-subunit of HIF-1 (HIF-1α) and P-gp were up-regulated. Furthermore, P-gp was up-regulated under experimental physiological hypoxia and chemical hypoxia induced by either cobalt chloride or desferrioxamine. The pro-oxidants H 2 O 2 and buthionine sulfoximine down-regulated HIF-1α and P-gp, whereas up-regulation was achieved with the radical scavengers dehydroascorbate, Nacetylcysteine, and vitamin E. The correlation of HIF-1α and P-gp expression was validated by the use of hepatoma tumor spheroids that were either wild type (Hepa1) or mutant (Hepa1C4) for aryl hydrocarbon receptor nuclear translocator (ARNT), i.e., HIF-1β. Chemical hypoxia robustly increased HIF-1α as well as P-gp expression in Hepa1 tumor spheroids, whereas no changes were observed in Hepa1C4 spheroids. Hence, our data demonstrate that expression of P-gp in multicellular tumor spheroids is under the control of HIF-1.
F irst insight into how hypoxia can develop in tumors was provided by Thomlinson and Gray (1) , who suggested that within the tissue of solid tumors viable hypoxic and hence radiotherapy-resistant and chemotherapy-resistant cells occurred at a constant distance (100-150 µm) between blood vessels and necrotic tissue in areas of reduced oxygen supply. This theory has withstood the test of time. There is also general consent that hypoxia in the depth of solid tumors dramatically decreases the chemosensitivity of tumor cells (2, 3) and that experimental hypoxia promotes drug resistance to anticancer agents in a variety of cell lines (4, 5) . Hypoxic cell areas have been identified in several studies, either by immunostaining of hypoxic cells in sections of rodent and human tumors (6) (7) (8) or by oxygen pressure measurements in tumor tissue by the use of needle electrodes (9) .
In a solid tumor in vivo, a number of factors associated either directly or indirectly with tumor hypoxia contribute to resistance to anticancer drugs (10) . Cells in hypoxic regions of a tumor stop or slow their rate of progression through the cell cycle (11) . This effect is the result of increased expression of specific proteins, e.g., the tumor suppressor p53 (12, 13) and the cyclindependent kinase inhibitor p27 Kip1 (14) , which are induced under hypoxic conditions. Because most anticancer drugs are more effective against rapidly proliferating cells than nonproliferating cells, this slowing of cell proliferation will lead to increased chemoresistance. Another way by which hypoxia may contribute to drug resistance is through reduced generation of endogenous nitric oxide (NO) under hypoxic conditions, as recently evidenced in Matthews et al. (15) . These authors demonstrated that pharmacological inhibition of NO generation abolished the drug resistance observed after hypoxic incubation of tumor cells.
However, no correlation between hypoxia and either increased expression or amplification of genes conferring multidrug resistance (MDR), e.g., the genes for the MDR transporters Pglycoprotein (P-gp), MDR-associated protein, or lung resistance-associated protein, has yet been presented. These genes, which constitute the major constraint to increased efficacy of chemotherapeutic anticancer agents, may be regulated by hypoxia-inducible factors (HIFs), which are stabilized under hypoxic conditions but undergo enhanced degradation under normoxia (16) (17) (18) (19) . Although of primordial scientific interest, the relation between hypoxia and HIFs and the increased expression of MDR transporters remains to be elucidated.
In previous studies, we reported the development of an intrinsic P-gp-mediated MDR in multicellular tumor spheroids of different origin, which was observed predominantly in quiescent cell areas in hypoxic regions of large tumor spheroids (20) (21) (22) . This intrinsic MDR was demonstrated to be regulated by the intracellular redox state, which is elevated in small tumor spheroids in the exponential growth phase but is reduced in large hypoxic tumor spheroids, which show a marked growth retardation (20, 21) . The aim of the present study was to demonstrate a correlation between the intrinsic expression of the MDR-associated P-gp and hypoxia in deeper cell layers of large multicellular tumor spheroids. Our data indicate that P-gp expression in large multicellular tumor spheroids is regulated by the hypoxic microenvironment in the depth of the tumor tissue and depends on a functionally active HIF-1/ARNT (aryl hydrocarbon receptor nuclear translocator) heterodimer.
MATERIALS AND METHODS

Cell culture techniques
The human prostate cancer cell line DU-145 was kindly provided by Dr. J. Carlsson, Uppsala, Sweden. The cells were grown routinely in 5% CO 2 /humidified air at 37°C with Ham's F10 medium (GIBCO, Life Technologies, Helgerman Court, MD) supplemented with 10% (v/v) FCS (Boehringer-Mannheim, Mannheim, Germany), 2 mM glutamine, 0.1 mM β-mercaptoethanol, 2 mM Eagle's minimum essential medium, 100 IU/ml penicillin, and 100 µg/ml streptomycin (ICN Flow, Meckenheim, Germany). The wild-type Hepa1 and the ARNT-deficient Hepa1C4 mouse hepatoma cell lines were grown in Dulbecco´s modified Eagle's medium supplemented with the same additives as described above. Cell monolayers were enzymatically dissociated with 0.2% (w/v) trypsin and 0.05% (w/v) EDTA (ICN Flow) and were seeded in siliconized 250-ml spinner flasks (Integra Biosciences, Fernwald, Germany) with 250 ml of complete medium; samples were agitated at 20 rpm by using a Cellspin stirrer system (Integra Biosciences). Cell culture medium was partially (100 ml) changed every day. For the experiments, either small tumor spheroids (diameter of 100 ± 50 µm) or large tumor spheroids (diameter of 350 ± 50 µm) before the onset of central necrosis were selected.
Incubation of tumor spheroids under hypoxic conditions
Hypoxic conditions were achieved by perfusing the spinner flasks with a gas mixture containing 1% O 2 , 94% N 2 , and 5% CO 2 . For the experiments under hypoxic conditions, small tumor spheroids were selected that expressed only low levels of P-gp. The hypoxic incubation was performed for 72 h.
Confocal laser scanning microscopy
Fluorescence recordings were performed by means of a confocal laser scanning setup (LSM 410, Carl Zeiss, Jena, Germany) equipped with 488-nm argon-ion laser and two helium-neon lasers with wavelengths of 543 and 633 nm. The confocal setup was connected to an inverted microscope (Axiovert 135, Carl Zeiss). Fluorophores were excited by using a 0.5-mW heliumneon laser (single excitation at 543 nm). A 25 ×, N.A. 0.8, oil immersion-corrected objective (Carl Zeiss) was applied. Fluorescence was measured in 3600-µm 2 areas at a depth of 60 µm from the spheroid surface. The thickness of the optical sections amounted to 20 µm.
Immunohistochemistry
Antibody staining was performed either with whole mount multicellular spheroids or with cryosections. The polyclonal anti-mdr (Ab-1) antibody (Oncogene Research Products, Cambridge, UK) was used at a concentration of 5 µg/ml in 0.01% phosphate-buffered saline supplemented with Triton X-100 (PBST). The monoclonal anti-HIF-1α (clone mgc3) (Alexis Biochemicals, Grünberg, Germany) was used at a dilution of 1:200. Spheroids were washed in PBS and were fixed in 4% paraformaldehyde in PBS at 4°C for 1 h. They were subsequently permeabilized in PBS supplemented with 1% (v/v) Triton X-100 (Sigma, Deisenhofen, Germany). Before spheroids were immunostained, they were incubated for 1 h in 0.01% PBST containing 10% fat-free milk powder to reduce nonspecific binding. Then the primary antibody was applied for 2 h at room temperature. After spheroids were washed three times in 0.01% PBST, they were incubated for 60 min in 0.01% PBST supplemented with 10% milk powder and a Cy5-conjugated F(ab') 2 fragment goat anti-rabbit IgG (H + L) (Boehringer-Mannheim) (concentration 4.6 µg/ml). Excitation was performed using a 633-nm helium-neon laser of the confocal setup. Emission was recorded using an LP655 nm filter set.
For quantitative immunohistochemistry, confocal images of whole mount multicellular spheroids stained with only secondary antibodies (background fluorescence image) and spheroids stained with primary and secondary antibodies were recorded. The pinhole settings of the confocal setup were adjusted to yield optical slices 20 µm thick. After subtraction of background fluorescence, the fluorescence signal (counts) was evaluated by the image analysis software of the confocal setup in 3600-µm 2 areas of interest and was routinely exported for further analysis by the Sigma Plot graphic software.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Expression of the mdr-1 gene was monitored by semiquantitative RT-PCR as described previously (23) . mdr-1 mRNA was amplified by using 5′-CCA ATG ATG CTG CTC AAG TT-3' as the forward primer and 5'-GTT CAA ACT TCT GCT CCT GA-3' as the reverse primer. The RT-PCR was normalized for 25, 27, and 29 cycles by using a hypoxanthine phosphoribosyltransferase (HPRT) cDNA fragment as a standard.
Measurement of reactive oxygen species (ROS) by H 2 DCFDA
Intracellular ROS levels were measured with the fluorescent dye 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA) (Molecular Probes, Eugene, OR), which is a nonpolar, nonfluorescent compound that is converted into a polar nonfluorescent derivative (H 2 DCF) by cellular esterases after it enters cells. H 2 DCF is membrane impermeable and is rapidly oxidized to the highly fluorescent 2',7'-dichlorofluorescein (DCF) in the presence of intracellular ROS. For the experiments, multicellular tumor spheroids were incubated in E1 medium containing (in mM) NaCl 135, KCl 5.4, CaCl 2 1.8, MgCl 2 1, glucose 10, and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) 10 (pH 7.4 at 23°C), and 20 µM H 2 DCFDA dissolved in dimethyl sulfoxide was added. After 5, 10, 15, 20, or 30 min of incubation intracellular DCF fluorescence (corrected for background fluorescence) was evaluated in 3600-µm 2 regions of interest by using an overlay mask. For fluorescence excitation, the 488-nm band of the argon-ion laser of the confocal setup was used. Emission was recorded using a longpass LP515 nm filter set.
Chemiluminescence measurements
H 2 O 2 release from DU-145 was determined according to Wymann et al. (24) , by using a luciferin-luciferase assay (Sigma) in a chemiluminescence apparatus (Bioluminiscence Analyzer XP2000, SKAN AG, Basel, Switzerland) under dim light. For data sampling, the output of the photomultiplier tube of the setup was connected to a multimeter (Voltcraft M-3610D, Conrad Electronics, Hirschau, Germany) and a personal computer. Multicellular tumor spheroids were incubated for 2 h in test buffer containing (in mM) 130 NaCl, 4.6 KCl, 1 CaCl 2 , 5 glucose, 20 HEPES, and 1.1 KH 2 PO 4 . The cell supernatant was subsequently collected and pressure injected into a quarz cuvette containing test buffer supplemented with 10 µM luminol (Molecular Probes), 100 µM sodium azide, and 2 U/ml horseradish peroxidase (Sigma), and the chemiluminescence signal was recorded every 0.3 s. The released amount of H 2 O 2 was calibrated by exogenous addition of H 2 O 2 in a concentration range of 1-20 nM and was related to the cell number by enzymatic dissociation of tumor spheroids with 0.2% (w/v) trypsin and 0.05% (w/v) EDTA (ICN Flow) and evaluation of the cell numbers by the use of an automatic cell counter (CASY1, Schärfe, Reutlingen, Germany).
PO 2 measurement with oxygen microelectrodes
PO 2 distribution profiles in multicellular tumor spheroids were measured in a perfusion chamber as described previously (25) . To stabilize the objects for perfusion with isotonic salt solution (Locke´s solution) and insertion of the microelectrode, they were positioned onto a small plastic plate containing bore holes. Single-channel microelectrodes with a tip diameter of 2-4 µm were used for polarographic PO 2 measurements. Two-point calibration was performed as described previously (25) .
Statistical analysis
Data are given as mean values ± SD, with n indicating the number of experiments. In each experiment, at least 20 multicellular spheroids were analyzed. Student´s t test for unpaired data was applied as appropriate. A value of P < 0.05 was considered significant.
RESULTS
Pericellular oxygen levels and ROS generation in multicellular tumor spheroids of different size classes
Pericellular oxygen pressures in the depth of multicellular tumor spheroids have been investigated by several authors, who showed conclusively that central regions of tumor spheroids display severe hypoxia (25) (26) (27) (28) (29) (30) as well as increased expression of the hypoxia-related gene coding for vascular endothelial growth factor (31) . In the present study, the pericellular oxygen pressure was evaluated on the surface as well as the center of multicellular DU-145 prostate tumor spheroids. The pericellular oxygen pressure significantly declined in the center of spheroids exceeding a diameter of 200 µm (Fig. 1A) (n = 5-9 tumor spheroids for each data point). Likewise, the pericellular oxygen pressure decreased at the surface of tumor spheroids larger then 200 µm, which indicated increased oxygen consumption in the rapidly proliferating cells in peripheral cell layers (see Fig. 1 A) . In parallel with the occurrence of hypoxic cell areas in the depth of the tissue, the endogenous generation of ROS declined, as evaluated by the use of the fluorescent ROS indicator H 2 DCFDA and luminol-enhanced chemiluminiscence (Fig. 1B) (n = 3). We previously showed that only very low levels of ROS are generated by large tumor spheroids containing extended areas of quiescent cells, whereas in small tumor spheroids consisting predominantly of rapidly deviding cells significant amounts of ROS are generated (21) . Because the redox-sensitive fluorescence indicator H 2 DCFDA may not be exclusively specific for ROS, chemiluminescence measurements were used to investigate the amount of H 2 O 2 released from tumor spheroids (see inset in Fig. 1 B) . Small multicellular tumor spheroids released significantly higher levels of H 2 O 2 compared with large tumor spheroids-19.7 ± 1.4 nM versus 6 ± 1.4 nM H 2 O 2 (1.7 × 10 5 cells/ml of test buffer), respectively (n = 3)-which corroborated our data for the redox-sensitive fluorescence dye H 2 DCFDA.
Expression of HIF-1α and P-gp in multicellular tumor spheroids of different size classes
The expression of HIF-1α is regulated by hypoxia as well as the levels of intracellular ROS. It was previously reported that regulation of HIF-1 activity is primarily determined by the stability of the HIF-1α protein, which is sensitive to intracellular ROS (32) . In the present study, the protein levels of HIF-1α as well as of P-gp were investigated in cryosections during the growth of multicellular tumor spheroids (Fig. 2) . HIF-1α expression increased in parallel with the expression of P-gp in larger multicellular tumor spheroids. Maximum values for expression of 994 ± 162% and 388 ± 32% for HIF-1α (n = 3) and P-gp (n = 3), respectively, were observed in large tumor spheroids (diameters of 350-400 µm) that are in the prenecrotic phase. The comparison of protein expression in peripheral areas compared with more central parts of tumor spheroids revealed that expression of HIF-1α as well as expression of P-gp was increased in the depth of the tissue where quiescent, hypoxic cell layers prevailed (see Fig. 2C ).
HIF-1α and P-gp levels under physiological hypoxia
Is there a correlation between HIF-1α expression and expression of P-gp? To answer this question, small tumor spheroids (50-100 µm), which express only low levels of HIF-1α and Pgp in normoxia, were incubated for 72 h at 1% O 2 . Subsequently, tumor spheroids were fixed and immunostained for either HIF-1α or P-gp protein. As expected, hypoxia significantly increased HIF-1α levels compared with the untreated control (n = 3) (Fig. 3) . In corroboration of our working hypothesis, hypoxia likewise significantly increased P-gp expression (n = 3), which indicated that the increased expression of P-gp observed in quiescent cell layers of large tumor spheroids is regulated by the low pericellular oxygen levels in the depth of the tissue.
Regulation of HIF-1α and P-gp by ROS and chemical hypoxia
ROS (e.g., H 2 O 2 ) have previously been shown to increase degradation of HIF-1α via the ubiquitin-proteasome pathway (33) . We recently demonstrated that expression of P-gp is downregulated on elevation of the intracellular redox state (20, 21) . To analyze the correlation between ROS and the expression of HIF-1α and P-gp, large multicellular spheroids (350-400 µm) expressing elevated levels of HIF-1α and P-gp were treated for 24 h with either 200 µM H 2 O 2 or 50 µM buthionine sulfoximine (BSO), which is known to raise ROS by depletion of the intracellular glutathione store (Fig. 4) . Treatment of multicellular tumor spheroids with BSO or H 2 O 2 significantly down-regulated HIF-1α protein levels to 45 ± 14% and 69 ± 18%, respectively (n = 3) (untreated control set to 100%). In parallel, levels of P-gp were downregulated by treatment with BSO or H 2 O 2 to 62 ± 8% and 63 ± 6%, respectively (n = 3) (untreated control set to 100%). In contrast, significant up-regulation of HIF-1α was observed when small tumor spheroids were treated with either 100 µM cobalt chloride (CoCl 2 ) (167 ± 28% of the untreated control, n = 3) or 130 µM desferrioxamine (DFA) (226 ± 61% of the untreated control, n = 3). Both compounds are known to induce chemical hypoxia in a variety of cell types. Comparable to the up-regulation of HIF-1α, the levels of P-gp in small tumor spheroids were significantly increased by treatment with either 100 µM CoCl 2 (248 ± 19% of the untreated control, n = 3) or 130 µM DFA (217 ± 33% of the untreated control, n = 3). In addition, incubation with CoCl 2 or DFA significantly reduced intracellular ROS levels (data not shown).
Taken together, the data in the present study demonstrate that ROS generation is increased in small tumor spheroids and down-regulated during further spheroid growth (see Fig. 1B) . Hence, the endogenous generation of ROS may contribute to the low levels of HIF-1α in small tumor spheroids and may likewise affect the expression of intrinsic P-gp. To investigate this notion, small tumor spheroids were incubated for 24 h with free radical scavengers: ammonium pyrrolidine dithiocarbamate (APDC) (0.2 µM), dehydroascorbate (DHA) (2.5 mM), vitamin E (30 µM), or N-acetylcysteine (NAC) (20 mM) (Fig. 5) . This treatment resulted in a significant reduction in DCF fluorescence, which indicated a decreased intracellular redox state (see Fig.  5A ) (n = 3). HIF-1α protein levels also increased, to 182 ± 20% (APDC, n = 3), 206 ± 14% (DHA, n = 3), 195 ± 17% (vitamin E, n = 3), and 191 ± 13% (NAC, n = 3) (untreated control set to 100%) (see Fig. 5B ). In parallel, increased expression of P-gp was observed after incubation of multicellular tumor spheroids with APDC (168 ± 16%, n = 3), DHA (151 ± 17%, n = 3), vitamin E (156 ± 23%, n = 3), or NAC (144 ± 23%, n = 3) (untreated control set to 100%) (see Fig. 5C ).
Expression of HIF-1α and P-gp under conditions of chemical hypoxia in HIF-1β/ARNTdeficient multicellular hepatoma tumor spheroids
The data of the present study suggest that expression of HIF-1α and P-gp is regulated by the pericellular oxygen level and/or the intracellular redox state in the depth of the tissue of multicellular tumor spheroids. To determine whether P-gp expression is under the control of HIF-1, hepatoma tumor spheroids that were either wild type (Hepa1) or mutant for HIF-1β/ARNT (Hepa1C4) were incubated for 24 h under conditions of chemical hypoxia, i.e., in the presence of either 100 µM CoCl 2 or 130 µM DFA. Protein expression of HIF-1α and P-gp was investigated (n=3) (Fig. 6) . Under hypoxia-mimicking conditions, HIF-1α in Hepa1 tumor spheroids increased to 170 ± 10% and 174 ± 11% for DFA and CoCl 2 , respectively (normoxic control set to 100%). In parallel, a comparable increase in P-gp expression to 166 ± 13% and 156 ± 14% for DFA and CoCl 2 was observed in tumor spheroids of the wild-type Hepa1 cell line (normoxic control set to 100%). In contrast, no significant increase was observed in the expression of HIF-1α and P-gp after chemical hypoxia in tumor spheroids of the HIF-1β/ARNTdeficient Hepa1C4 cell line, which indicated that P-gp expression is under the control of HIF-1.
The induction of P-gp may occur on the translational rather than the transcriptional level. To investigate this issue, semiquantitative RT-PCR was performed (Fig. 7) . It was clearly evident that chemical hypoxia resulted in an increase in mdr-1 mRNA in Hepa1 tumor spheroids, whereas no induction of the mdr-1 gene occurred in the HIF-1β/ARNT-deficient Hepa1C4 cell line (n = 3). This indicates that chemical hypoxia results in induction of the mdr-1 gene rather than regulation of P-gp expression on the translational or post-translational level.
DISCUSSION
Hypoxia is well known to induce resistance to drugs and radiation in solid tumors (34) (35) (36) (37) as well as in multicellular tumor spheroids (38, 39) . The reason that hypoxia contributes to drug resistance in anticancer therapy has not yet been established. It has been demonstrated that hypoxia reduces the expression of DNA topoisomerase IIα, which renders cells resistant to topoisomerase II-targeted drugs such as etoposide and doxorubicin (40) . Furthermore, glutathione S-transferase pi (GST-pi), which has been demonstrated to be involved in the MDR phenotype, has recently been shown to be up-regulated by hypoxia in several cancer cell lines (41) . A correlation between P-gp and GST-pi has been reported (42); this report indicated that there may be a common mechanism for regulating the expression of drug resistance-related proteins.
Our data demonstrate that HIF-1α and P-gp are up-regulated with increasing growth of multicellular tumor spheroids, which suggests that expression of both proteins is regulated by the same tissue microenvironment. Because the pericellular oxygen pressure in the center of the tissue as well as in the periphery decreased with increasing tumor spheroid size, we hypothesized that expression of P-gp in large tumor spheroids is regulated by hypoxia. Moreover, we demonstrated that, parallel to the decrease in the pericellular oxygen pressure, endogenous generation of ROS was down-regulated during growth of tumor spheroids. This result is due to the reduced availability of oxygen for ROS generation in a hypoxic microenvironment (43) , as well as to a decrease in expression of the ROS-generating NADPH oxidase in large multicellular tumor spheroids (21) .
Endogenous generation of ROS is a common feature of tumor cells and may regulate neoplastic cell growth (44) . Previous studies of our group (20, 21) as well as the present study demonstrate that P-gp expression in multicellular tumor spheroids is regulated by intracellular ROS levels. Down-regulation of HIF-1α levels by ROS (e.g., H 2 O 2 ) has been conclusively demonstrated by several authors (32, 45, 46) and has been attributed to enhanced proteasomal degradation. We therefore assumed that endogenously generated ROS in small multicellular tumor spheroids may be involved in the maintainance of low levels of HIF-1α as well as P-gp. This assumption was validated by experiments in which small tumor spheroids expressing low levels of HIF-1α and P-gp were treated with free radical scavengers, which consequently significantly up-regulated the expression of both proteins. It was recently reported that HIF-1α is hydroxylated at Pro564 by a prolyl hydroxylase enzyme, which is necessary for binding of the von Hippel-Lindau protein (pVHL) (47, 48) . pVHL organizes the assembly of a complex that activates the ubiquitin E3 ligase, which then ubiquitinates HIF-1α and thereby targets it for degradation (49) . It was shown that nonenzymatic oxidation systems failed to promote specific interactions of HIF-1α sequences with pVHL, which challenges the role of ROS in HIF-1α degradation (47) . However, as discussed in this report, these results did not exclude the possibility that direct oxidation processes or other oxygen-sensing systems impinge on HIF at other sites or on components of the enzymatic prolyl hydroxylation complex (47) .
The regulation of P-gp by hypoxia has not yet been investigated. In a previous study performed with EMT6/Ro cells, no induction of P-gp mRNA by hypoxia was observed (38) . In the present study, a pronounced up-regulation of HIF-1α as well as P-gp was achieved by cultivation of small tumor spheroids under low oxygen pressure (physiological hypoxia) as well as after treatment with CoCl 2 and DFA, which are known to induce chemical hypoxia. These observations conclusively demonstrate that P-gp expression in multicellular tumor spheroids is regulated by the pericellular oxygen pressure, which is a critical determinant of the amount of ROS present in the tissue. In contrast, an elevation of intracellular ROS in large, hypoxic, and drug-resistant tumor spheroids down-regulated HIF-1α and P-gp levels, which corroborated our previous studies of redox regulation of P-gp (20, 21) , as well as the studies of others describing increased degradation of HIF-1α by the ubiquitin/proteasome pathway under conditions of an elevated intracellular redox state (32, 45, 50) .
The apparent correlation of HIF-1α and P-gp expression was investigated in more detail by the use of multicellular tumor spheroids grown from an HIF-1β/ARNT mutant hepatoma cell line (Hepa1C4) that was originally selected for its resistance against 3,4-benzopyrene treatment. This cell line is functionally deficient in HIF-1β/ARNT (51) and is unable to form the HIF-1 heterodimer (52, 53) . As expected, expression of HIF-1α and P-gp was up-regulated in wild-type Hepa1 tumor spheroids cultivated under conditions of chemical hypoxia. In contrast, upregulation of HIF-1α and P-gp was absent in the HIF-1β/ARNT mutant cell line Hepa1C4, which clearly indicates that hypoxia does not up-regulate P-gp independently of HIF-1 but that the observed induction of P-gp under hypoxic conditions is closely linked to an intact HIF-1 heterodimer. A previous study performed with hepatoma cells grown in monolayer culture demonstrated that chemical hypoxia induced HIF-1α accumulation in cell nuclei of the ARNTdeficient Hepa1C4 cell line, although to a much lesser extent compared with wild-type Hepa1 cells (54) . Compared with monolayer cultures, tumor spheroids display significantly elevated levels of HIF-1α, owing to oxygen gradients occurring in three-dimensional avascular tissues. These intrinsically elevated levels of HIF-1α may account for the lack of induction of HIF-1α in multicellular hepatoma tumor spheroids under conditions of chemical hypoxia.
The data of the present study demonstrate that intrinsic expression of P-gp in multicellular tumor spheroids is regulated by hypoxic conditions in the depth of the tissue and requires the presence of HIF-1α. However, it is currently unknown how HIF-1α may regulate the expression of P-gp. The sequenced mdr-1 gene coding for P-gp was cloned several years ago (55-57) and does not contain any HIF-1 binding sites, which suggests that P-gp is not under the direct control of HIF-1 but may be indirectly regulated, e.g., by transactivation. However, it cannot be excluded that the hypoxia response elements of genes binding to HIF-1 are located at some distance from the coding region of the gene. It was recently demonstrated that induction of the murine mdr-1 gene by the polycyclic aromatic hydrocarbon 3-methylcholanthrene requires a functional heterodimer of the aromatic hydrocarbon receptor and ARNT as well as activation of the tumor suppressor and transcription factor p53. This finding indicates that under the experimental conditions used in the present study, i.e., under hypoxia, mdr-1 expression may require a functional HIF-1α/ARNT heterodimer and presumably activation of p53. In this respect, it has been convincingly shown that mutant p53 up-regulates the mdr-1 gene via Ets-1 (58), which is a transcription factor under the control of HIF-1 and up-regulated under hypoxic conditions (59) . Furthermore, HIF-1α may regulate mdr-1 expression via protein kinase A-dependent activation of cAMP-positive factors, which were previously shown to exert a positive regulatory effect on mdr-1 transcription (60). The cAMP response element binding factor (CREB) promotes cellular gene expression, after its phosphorylation at Ser133, via recruitment of the coactivator paralogs CREB binding protein (CBP) and p300. CBP and p300 appear to mediate target gene induction via their association with RNA polymerase II complexes and intrinsic histone acetyltransferase activities that mobilize promotor-bound nucleosomes (61) . In this respect, histone acetyltransferase recruitment to the mdr-1 gene was recently shown to underlie the activation of mdr-1 by the transcription factor NF-Y (62, 63) . The carboxyl terminus of HIF-1α directly recruits CBP/p300 in a hypoxia-dependent manner (64) . In contrast, CBP can acetylate the carboxyl-terminal domain p53, thereby stimulating specific DNA binding activity by p53 (65) . Thus, it was hypothesized that p53 and HIF-1α functions are differently regulated by CBP and may independently activate transcription, e.g., transcription of the mdr-1 gene. Alternatively, a convergence of CBP-dependent, HIF-1α-and p53-mediated pathways may be required for activation of the mdr-1 gene and establishment of the MDR phenotype.
The dissection of the multistep regulation of mdr-1 gene under hypoxic conditions is just beginning. Further studies will add to the understanding of how hypoxia induces drug resistance in the depth of the tissue of solid tumors and will help exploitation of tumor hypoxia in cancer treatment. 
